It has been found that mTOR signaling is not only deregulated in cancer but also in different pathological conditions and the mTOR pathway is critical to the pathogenesis of HIV-related malignancies [42] and different autoimmune diseases [43]. This evidence concerns the gene MTOR and cancer.